135 related articles for article (PubMed ID: 29605973)
1. Could Improvement in Subjective Well-being Relieve Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome?
Jang SH; Kim YS
J Neurogastroenterol Motil; 2018 Apr; 24(2):164-165. PubMed ID: 29605973
[No Abstract] [Full Text] [Related]
2. Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.
Lee SH; Kim CR; Kim KN
Am J Med Sci; 2019 Jan; 357(1):23-28. PubMed ID: 30611316
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms.
Kilkens TO; Honig A; Rozendaal N; Van Nieuwenhoven MA; Brummer RJ
Aliment Pharmacol Ther; 2003 Jan; 17(1):43-51. PubMed ID: 12492731
[TBL] [Abstract][Full Text] [Related]
4. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
Lackner JM; Jaccard J; Keefer L; Brenner DM; Firth RS; Gudleski GD; Hamilton FA; Katz LA; Krasner SS; Ma CX; Radziwon CD; Sitrin MD
Gastroenterology; 2018 Jul; 155(1):47-57. PubMed ID: 29702118
[TBL] [Abstract][Full Text] [Related]
5. The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome.
Katsumata R; Shiotani A; Murao T; Ishii M; Fujita M; Matsumoto H; Haruma K
J Clin Biochem Nutr; 2018 May; 62(3):270-276. PubMed ID: 29892168
[TBL] [Abstract][Full Text] [Related]
6. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.
Labus JS; Mayer EA; Chang L; Bolus R; Naliboff BD
Psychosom Med; 2007 Jan; 69(1):89-98. PubMed ID: 17244851
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome.
Tack J; Middleton SJ; Horne MC; Piessevaux H; Bloor JS; Meyers NL; Palmer RM
Aliment Pharmacol Ther; 2006 Jun; 23(11):1655-65. PubMed ID: 16696817
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S
Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501
[TBL] [Abstract][Full Text] [Related]
10. Does a physically active lifestyle improve symptoms in women with irritable bowel syndrome?
Lustyk MK; Jarrett ME; Bennett JC; Heitkemper MM
Gastroenterol Nurs; 2001; 24(3):129-37. PubMed ID: 11847862
[TBL] [Abstract][Full Text] [Related]
11. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
Smith GD
J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease.
Thompson WG
Gut; 1984 Oct; 25(10):1089-92. PubMed ID: 6479683
[TBL] [Abstract][Full Text] [Related]
13. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
14. Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls.
Masuy I; Van Oudenhove L; Tack J; Biesiekierski JR
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28762592
[TBL] [Abstract][Full Text] [Related]
15. Manning criteria in irritable bowel syndrome: its diagnostic significance.
Jeong H; Lee HR; Yoo BC; Park SM
Korean J Intern Med; 1993 Jan; 8(1):34-9. PubMed ID: 8268145
[TBL] [Abstract][Full Text] [Related]
16. Reduced Symptoms of Post-Traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans.
Harding K; Simpson T; Kearney DJ
J Altern Complement Med; 2018 Dec; 24(12):1159-1165. PubMed ID: 30160516
[No Abstract] [Full Text] [Related]
17. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
Pimentel M; Chow EJ; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
[TBL] [Abstract][Full Text] [Related]
18. Health problems associated with irritable bowel syndrome: analysis of a primary care registry.
Clevers E; Vaes B; Henrard S; Goderis G; Tack J; Törnblom H; Simrén M; Van Oudenhove L
Aliment Pharmacol Ther; 2018 May; 47(10):1349-1357. PubMed ID: 29572885
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: The treatment of irritable bowel syndrome.
Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
